BPC-157 for Horses

📄 5 PubMed citations

Owners ask about BPC-157 for equine tendon and ligament injuries and about oral vs injectable forms. Here is the mechanism evidence, the practical questions, and why any equine dose you see is a guess.

🔬 There is no equine BPC-157 study at all. We are explicit about that instead of scaling a human or rodent dose to a 500 kg animal. We cover mechanism (rodent), the oral-vs-injection question, and reconstitution basics.

🧪 Buy BPC-157 (Arginine Salt) at Swiss Chems →

Code HIGHPEP10 — 10% off regular-priced items

Equine BPC-157 studies

Non-equine PK study (rats + dogs)

Published equine doses

Mechanism of Action

How It Works

🧬

Tendon & ligament repair (rodent)

BPC-157 promoted tendon-cell outgrowth and migration (PMID 21030672) and improved ligament healing (PMID 20225319) in rats. Equine tendon/ligament injuries are common, but these are rat models.

💊

Oral vs injection

BPC-157 is claimed to survive the gut and is sold as oral capsules and as injectable. The one pharmacokinetic study (rats + beagle dogs) measured IV and intramuscular routes (PMID 36588717); oral bioavailability in horses specifically is unstudied.

🐎

The equine unknown

No pharmacokinetic, efficacy, or safety study of BPC-157 exists in horses (PubMed "BPC-157 horse/equine": 0 results, 2026). Doses circulating online are extrapolations, not data. Horses are also subject to competition anti-doping rules.

Data

What the Data Shows

Rodent tendon/ligament studies

mechanistic

Multiple

Cross-species PK study

rats + beagle dogs

Equine BPC-157 studies

PubMed, 2026

⚠️ There is no published equine dose for BPC-157 — not oral, not injectable. We will not print a horse dose, because none has been established and a wrong extrapolation to a 500 kg animal is exactly how people get hurt. An equine veterinarian is the right source, and competition horses face anti-doping rules.

Bottom Line

Key Takeaways

✅ What We Know

BPC-157 improved tendon and ligament healing in rodent models (PMID 21030672, 20225319).
A cross-species pharmacokinetic study covered rats and beagle dogs (PMID 36588717); horses were not included.
BPC-157 is sold in both oral-capsule and injectable forms.
Equine tendon and suspensory-ligament injuries are common and slow to heal, which is why owners ask.

⚠️ What We Don't Know

No equine study of BPC-157 exists (PubMed: 0 results, 2026).
No published oral or injectable dose for horses; any figure online is a guess.
Oral bioavailability in horses is unmeasured.
Anti-doping status in competition horses must be checked before use.

FAQ

Frequently Asked Questions

What is the BPC-157 dose for a horse?

There isn’t a published one. No pharmacokinetic, efficacy, or safety study of BPC-157 has been done in horses, so any specific equine dose you find online is an extrapolation, not data. Scaling a human or rat dose to a 500 kg horse is guesswork; consult an equine veterinarian.

How would you give BPC-157 to a horse — oral or injection?

Both forms exist (oral capsules and injectable reconstituted in bacteriostatic water), but the one pharmacokinetic study measured IV and intramuscular routes in rats and dogs, not oral dosing in horses. Which route works in a horse is simply unstudied.

Is BPC-157 allowed in competition horses?

Peptides like BPC-157 are widely treated as prohibited or unapproved substances under equine anti-doping frameworks. Check the specific rules of your competition body and talk to your vet before considering it.

🧪 Buy BPC-157 (Arginine Salt) — Research Grade

Swiss Chems publishes third-party HPLC COAs for selected products — vendor-published, a claim to verify. Deep-linked to the BPC-157 (Arginine Salt) product page.

Buy BPC-157 (Arginine Salt) at Swiss Chems →

Code HIGHPEP10 — 10% off regular-priced items

Affiliate links — support HighPeptides at no extra cost.